Requires health insurance coverage of prescribed anti-obesity medication.

This bill (A 943) requires all health insurance plans sold in New Jersey - including hospital service contracts, medical service corporations, individual policies, group plans, and health maintenance organizations - to cover FDA-approved anti-obesity medications for chronic weight management. It mandates that coverage for these medications be provided "to the same extent as for any other medical condition" under the policy, meaning no additional cost-sharing or restrictions beyond standard medical coverage. The law applies to all plans issued or renewed in New Jersey after its effective date, affecting millions of residents enrolled in private health insurance. It specifically defines covered medications as those approved by the FDA for obesity treatment, not lifestyle products. The bill does not change premiums or create new funding mechanisms - it simply requires existing insurance plans to include these medications in standard coverage.